Brief: Ascelia Pharma Q2 Operating Loss At SEK 32.7 Mln

Ascelia Pharma AB

18/08/2022 07:40

Aug 18 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * HALF-YEAR REPORT 2022: STRONG RESULTS FROM ORVIGLANCE FOOD
EFFECT STUDY
    * Q2 OPERATING LOSS SEK 32.7 MILLION VERSUS LOSS SEK 32.3
MILLION
YEAR AGO
    * Q2 CASH FLOW FROM OPERATIONS OF SEK -32.7M (SEK -30.6M)

Source text for Eikon:  ID:nMFN4tD46H 
Further company coverage:  ACELP.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))